Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1Giuseppe Giaccone, David H. Johnson, Roy S. Herbst et al.|Journal of Clinical Oncology|2004Cited by 1.7k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung CancerChristopher G. Azzoli, Giuseppe Giaccone, Sherman Baker et al.|Journal of Clinical Oncology|2009Cited by 913
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.Giuseppe Giaccone, Herbert M. Pinedo, Cornelis J. A. Punt et al.|PubMed|2002Cited by 507
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Guido Kroemer, Enrico Lugli et al.|Oncotarget|2014Cited by 469
Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue DamageHerbert M. Pinedo, B. Mary E. von Blomberg, Nobusuke Nishi et al.|Clinical Immunology|2001Cited by 270